Collegium Pharmaceutical, Inc. Profile Avatar - Palmy Investing

Collegium Pharmaceutical, Inc.

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta …

Drug Manufacturers - Specialty & Generic
US, Stoughton [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

Collegium Pharmaceutical, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

Collegium Pharmaceutical, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of Collegium Pharmaceutical, Inc..

End of COLL's Analysis
CIK: 1267565 CUSIP: 19459J104 ISIN: US19459J1043 LEI: - UEI: -
Secondary Listings
COLL has no secondary listings inside our databases.